A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clinical application, including ...
Bio & Medicine
Jul 7, 2017
0
40
(PhysOrg.com) -- Diagnosis and treatment form the basis of modern medicine. Traditionally, they are two separate steps; however, it doesn’t have to be that way. The term “theranostic” refers to the combination ...
Bio & Medicine
Mar 1, 2011
0
1
For a long time a relationship between infertility and chemotherapeutic agents has been assumed. Now, the mechanism has been elucidated. Mainly women are affected because the quality control in the oocytes is different from ...
Biochemistry
Feb 22, 2011
0
0
One of the challenges that cancer researchers face in designing new antitumor agents is that of predicting how drug molecules will behave in the complex microenvironment that surrounds a tumor. In particular, tumors create ...
Biochemistry
Feb 23, 2009
1
0
(Phys.org) —Berkeley Lab researchers have shown that tiny bubbles carrying hyperpolarized xenon gas hold big promise for NMR (nuclear magnetic resonance) and its sister technology, MRI (Magnetic Resonance Imaging), as these ...
Analytical Chemistry
Jul 16, 2013
0
0
Living cells inside the body could be placed under surveillance—their location and migration noninvasively tracked in real time over many days—using a new method developed by researchers at KAUST.
Bio & Medicine
May 20, 2020
0
24
(PhysOrg.com) -- The copper sequestering drug tetrathiomolybdate (TM) has been shown in studies to be effective in the treatment of Wilson disease, a disease caused by an overload of copper, and certain metastatic cancers. ...
Analytical Chemistry
Nov 26, 2009
0
0
Chemotherapy drug resistance contributes to treatment failure in more than 90 percent of metastatic cancers. Overcoming this hurdle would significantly improve cancer survival rates.
Bio & Medicine
Mar 9, 2011
0
0
Researchers at ETH Zurich recently demonstrated that platinum nanoparticles can be used to kill liver cancer cells with greater selectivity than existing cancer drugs.
Bio & Medicine
Feb 14, 2019
0
56
In a technical tour de force, scientists at Fox Chase Cancer Center have cataloged and cross-indexed the actions of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes critical ...
Biotechnology
Oct 30, 2011
0
0
